MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Burning Rock Biotech Limited Total Inventories 2011-2026 | BNR
Annual Total Inventories Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 123 M | 68 M | 58.1 M | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 123 M | 58.1 M | 83.1 M |
Quarterly Total Inventories Burning Rock Biotech Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 123 M | - | - | - | 68 M | - | - | - | 58.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 123 M | 58.1 M | 83.1 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
13.3 M | $ 1.24 | -15.65 % | $ 1.58 M | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 39.73 | 1.44 % | $ 1.1 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.66 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
2.33 B | $ 219.15 | -0.14 % | $ 160 B | USA |
 |
Exact Sciences Corporation
EXAS
|
162 M | $ 102.44 | 0.13 % | $ 19 B | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
Guardant Health
GH
|
71.1 M | $ 113.64 | 2.86 % | $ 13.9 B | USA |
 |
DexCom
DXCM
|
560 M | $ 73.4 | -0.81 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
19.5 M | $ 20.69 | -0.53 % | $ 1.11 B | USA |
 |
DarioHealth Corp.
DRIO
|
5.06 M | $ 9.94 | -3.54 % | $ 282 M |  Israel |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
68 M | $ 66.97 | 0.44 % | $ 4.63 B | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
547 M | $ 145.56 | -2.76 % | $ 23.1 B | USA |
 |
NeoGenomics
NEO
|
26.7 M | $ 12.04 | -2.9 % | $ 1.52 B | USA |
 |
QIAGEN N.V.
QGEN
|
279 M | - | - | $ 10.6 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
279 M | $ 210.54 | -0.57 % | $ 10.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
188 M | $ 186.85 | 2.49 % | $ 20.7 B | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
384 K | $ 24.53 | 1.11 % | $ 31.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
493 M | $ 271.48 | 0.62 % | $ 22.8 B | USA |
 |
Mettler-Toledo International
MTD
|
342 M | $ 1 381.85 | -0.79 % | $ 29.3 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 180.78 | -2.75 % | $ 14.9 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
382 M | $ 674.26 | -0.36 % | $ 55.6 B | USA |
 |
Agilent Technologies
A
|
830 M | $ 133.38 | 0.11 % | $ 40.5 B | USA |
 |
Biomerica
BMRA
|
1.49 M | $ 2.36 | -1.26 % | $ 5.42 M | USA |